Early application of low-dose glucocorticoid improves acute respiratory distress syndrome: A meta-analysis of randomized controlled trials

Experimental and Therapeutic Medicine

Volumn 13, Issue 4, 2017, Pages 1215-1224

  Yang, Zhi Gang ^a   Lei, Xiao Li ^a   Li, Xiao Liang ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Acute respiratory distress syndrome; Effect; Glucocorticoid; Meta analysis; Mortality

Indexed keywords

GLUCOCORTICOID;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; HUMAN; INFECTION RATE; INFLAMMATION; LOW DRUG DOSE; LUNG INJURY; META ANALYSIS; MULTIPLE ORGAN FAILURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VENTILATOR WEANING;

EID: 85013844194     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2017.4154     Document Type: Article

References (38)

1. Koh Y: Update in acute respiratory distress syndrome. J Intensive Care 2: 2, 2014.
2. Del Sorbo L and Slutsky AS: Acute respiratory distress syndrome and multiple organ failure. Curr Opin Crit Care 17: 1-6, 2011.
3. Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, Mercier E, Badet M, Mercat A, Baudin O, et al; PROSEVA Study Group: Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 368: 2159-2168, 2013.
4. Mondrinos MJ, Kennedy PA, Lyons M, Deutschman CS and Kilpatrick LE: Protein kinase C and acute respiratory distress syndrome. Shock 39: 467-479, 2013.
5. Carnesecchi S, Pache JC and Barazzone-Argiroffo C: NOX enzymes: Potential target for the treatment of acute lung injury. Cell Mol Life Sci 69: 2373-2385, 2012.
6. Carnesecchi S, Dunand-Sauthier I, Zanetti F, Singovski G, Deffert C, Donati Y, Cagarelli T, Pache JC, Krause KH, Reith W and Barazzone-Argiroffo C: NOX1 is responsible for cell death through STAT3 activation in hyperoxia and is associated with the pathogenesis of acute respiratory distress syndrome. Int J Clin Exp Pathol 7: 537-551.eCollection 2014, 2014.
7. Meduri G, Bell W, Sinclair S and Annane D: Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment. Presse Med 40: e543-e560, 2011.
8. Vandevyver S, Dejager L, Tuckermann J and Libert C: New insights into the anti-inflammatory mechanisms of glucocorticoids: An emerging role for glucocorticoid-receptor-mediated transactivation. Endocrinology 154: 993-1007, 2013.
9. Nixon M, Andrew R and Chapman KE: It takes two to tango: Dimerisation of glucocorticoid receptor and its anti-inflammatory functions. Steroids 78: 59-68, 2013.
10. Headley AS, Tolley E and Meduri GU: Infections and the inflammatory response in acute respiratory distress syndrome. Chest 111: 1306-1321, 1997.
11. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R and Leeper K: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107: 1062-1073, 1995.
12. Lamontagne F, Briel M, Guyatt GH, Cook DJ, Bhatnagar N and Meade M: Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome and severe pneumonia: A meta-analysis of randomized controlled trials. J Crit Care 25: 420-435, 2010.
13. Rocco PR, Souza AB, Faffe DS, Pássaro CP, Santos FB, Negri EM, Lima JG, Contador RS, Capelozzi VL and Zin WA: Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury. Am J Respir Crit Care Med 168: 677-684, 2003.
14. Confalonieri M, Annane D, Antonaglia C, Santagiuliana M, Borriello EM and Meduri GU: Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia? Curr Infect Dis Rep 15: 158-166, 2013.
15. Matthay MA, Song Y, Bai C and Jones KD: The acute respiratory distress syndrome in 2013. Translational Respiratory Medicine 1: 1-6, 2013.
16. Thompson BT: Corticosteroids for ARDS. Minerva Anestesiol 76: 441-447, 2010.
17. Wajanaponsan N, Reade MC and Milbrandt EB: Steroids in late ARDS? Crit Care 11: 310, 2007.
18. Hwangbo B, Lee HS, Lee JM, Kim MS, Kim HY, Choi YJ and Zo JI: Low dose steroid therapy at an early phase of acute respiratory distress syndrome after thoracic surgery. Chest Journal 126: 719S-a-719S, 2004.
19. Fremont RD and Rice T: Low-dose steroids in ARDS. Chest 132: 1095, 2007.
20. Peter JV, John P, Graham PL, Moran JL, George IA and Bersten A: Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: Meta-analysis. BMJ 336: 1006-1009, 2008.
21. Higgins J and Altman DG: Assessing risk of bias in included studies. Cochrane handbook for systematic reviews of interventions. Wiley-Blackwell, Chichester: pp187-241, 2008.
22. Weigelt JA, Norcross JF, Borman KR and Snyder WH III: Early steroid therapy for respiratory failure. Arch Surg 120: 536-540, 1985.
23. Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, Kariman K, Higgins S, Bradley R, Metz CA, et al: High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 317: 1565-1570, 1987.
24. Marik P, Kraus P, Sribante J, Havlik I, Lipman J and Johnson DW: Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study. Chest 104: 389-392, 1993.
25. Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Della Porta R, Giorgio C, Blasi F, Umberger R and Meduri GU: Hydrocortisone infusion for severe community-acquired pneumonia: A preliminary randomized study. Am J Respir Crit Care Med 171: 242-248, 2005.
26. Annane D, Sébille V and Bellissant E; Ger-Inf-05 Study Group: Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 34: 22-30, 2006.
27. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT and Ancukiewicz M; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network: Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354: 1671-1684, 2006.
28. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M and Umberger R: Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 131: 954-963, 2007.
29. Mikami K, Suzuki M, Kitagawa H, Kawakami M, Hirota N, Yamaguchi H, Narumoto O, Kichikawa Y, Kawai M, Tashimo H, Arai H, Horiuchi T and Sakamoto Y: Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization. Lung 185: 249-255, 2007.
30. Wan MH, Li J, Gong HL, Xue P, Zhu L, Chen GY, Xia Q and Wen-Fu T: Clinical observation on the effect of dexamethasone and Chinese herbal decoction for purgation in severe acute pancreatitis patients. Chin J Integr Med 17: 141-145, 2011.
31. Ferguson N, Adhikari N, Cook D, Hand L, Henzler D, Zhou Q, Meade M and Lamontagne F: Corticosteroid use in ARDS patients enrolled in the oscillation for ARDS treated early (oscillate) trial. Am J Respir Crit Care Med 183: A1169, 2011.
32. Azevedo AF, Miranda-Filho DB, Henriques-Filho GT, Leite A and Ximenes RA: Randomized controlled trial of pulse methyl prednisolonex placebo in treatment of pulmonary involvement associated with severe leptospirosis. [ISRCTN74625030]. BMC Infect Dis 11: 186, 2011.
33. Seam N, Meduri GU, Wang H, Nylen ES, Sun J, Schultz MJ, Tropea M and Suffredini AF: Effects of methylprednisolone infusion on markers of inflammation, coagulation and angiogenesis in early acute respiratory distress syndrome. Crit Care Med 40: 495-501, 2012.
34. Liu L, Li J, Huang YZ, Liu SQ, Yang CS, Guo FM, Qiu HB and Yang Y: The effect of stress dose glucocorticoid on patients with acute respiratory distress syndrome combined with critical illness-related corticosteroid insufficiency. Zhonghua Nei Ke Za Zhi 51: 599-603, 2012 (In Chinese).
35. Thompson BT: Glucocorticoids and acute lung injury. Crit Care Med 31 (Suppl 4): S253-S257, 2003.
36. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M and Umberger R: Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial. Chest 131: 954-963, 2007.
37. Suter PM: Lung inflammation in ARDS - friend or foe? N Engl J Med 354: 1739-1742, 2006.
38. Annane D: Glucocorticoids for ARDS: Just do it! Chest 131: 945-946, 2007.